WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012052524) USE OF SPECIFIC GENES FOR THE PROGNOSIS OF LUNG CANCER AND THE CORRESPONDING PROGNOSIS METHOD
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/052524    International Application No.:    PCT/EP2011/068375
Publication Date: 26.04.2012 International Filing Date: 20.10.2011
IPC:
C12Q 1/68 (2006.01), G01N 33/543 (2006.01)
Applicants: UNIVERSITE JOSEPH FOURIER [FR/FR]; 621, avenue Centrale Domaine universitaire BP 53 F-38041 Grenoble Cedex 09 (FR) (For All Designated States Except US).
PISON-ROUSSEAUX, Sophie [FR/FR]; (FR) (For US Only).
KHOCHBIN, Saadi [FR/FR]; (FR) (For US Only)
Inventors: PISON-ROUSSEAUX, Sophie; (FR).
KHOCHBIN, Saadi; (FR)
Agent: GROSSET-FOURNIER, Chantal; GROSSET-FOURNIER & DEMACHY 54, rue Saint-Lazare F-75009 Paris (FR)
Priority Data:
10306142.0 20.10.2010 EP
Title (EN) USE OF SPECIFIC GENES FOR THE PROGNOSIS OF LUNG CANCER AND THE CORRESPONDING PROGNOSIS METHOD
(FR) UTILISATION DE GÈNES SPÉCIFIQUES POUR PRONOSTIQUER LE CANCER DU POUMON ET MÉTHODE PRONOSTIQUE CORRESPONDANTE
Abstract: front page image
(EN)The invention relates to the use of at least 13 genes chosen among a set of 28 genes for carrying out a method for identifying at least 66% of patients of those having a survival rate of at most about 20% at 30 months, among a population of patients afflicted by lung cancer having an estimated survival rate of at least 30% at 30 months based on the diagnosis of said lung cancer according to histopathological criteria.
(FR)Cette invention concerne l'utilisation d'au moins 13 gènes choisis parmi un groupe de 28 pour la mise en œuvre d'une méthode permettant d'identifier au moins 66 % des patients ayant un taux de survie d'au plus environ 20 % à 30 mois parmi une population de patients atteints du cancer du poumon ayant un taux de survie estimé d'au moins 30 % à 30 mois, sur la base du diagnostic dudit cancer du poumon d'après des critères histopathologiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)